Insight

Insight

Two ways to minimise the impact of COVID-19 on vulnerable communities

News

News

Hikma expands generics portfolio with Everolimus Tablets launch

Update

Update

Hikma update regarding COVID-19

Our 2019 preliminary results

Check out the highlights of our 2019 financial performance in this short video summary

Case study

Case study

Our support and impact for the Healthy Kitchen Project

Case study

Case study

Our support and impact; improving patient’s access to ritonavir

News

News

Hikma delivers strong growth in revenue and profit in 2019

CSR News

CSR News

Hikma supports teachers in Jordan through new partnership with Save the Children

Find out more

Who we are. We make high quality medicines and make them accessible to the people that need them.

Our impact

Our impact

The impact we have on people's lives is important, positive and far-reaching, listen to the stories of people whose lives we touch.

Find out more

Find out more

Our commitment to sustainability

Find out more

Find out more

We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide.